Role of Neuroimmune Crosstalk in Mediating the Anti-inflammatory and Analgesic Effects of Acupuncture on Inflammatory Pain

Dou et al. · Frontiers in Neuroscience · 2021

📚Narrative Review🔬n=97 basic studies analyzedHigh Scientific Impact

Evidence Level

STRONG
85/ 100
Quality
4/5
Sample
4/5
Replication
5/5
🎯

OBJECTIVE

To review the mechanisms of acupuncture in inflammatory pain through neuroimmune communication

👥

WHO

Analysis of 97 studies in animal models of inflammatory pain

⏱️

DURATION

Review of studies from 2010-2020

📍

POINTS

ST-36 (70 studies), GB-30, BL-60, SP-6, GB-34

🔬 Study Design

97participants
randomization

Basic studies

n=97

Various models of inflammatory pain

Clinical studies

n=113

Clinical applications of acupuncture

⏱️ Duration: Review covering 10 years

📊 Results in numbers

70/97

ST-36 was the most commonly used point

>80%

Electroacupuncture was the predominant technique

2-10 Hz

Most commonly used frequencies

1-2 mA

Typical intensity

Percentage highlights

>80%
Electroacupuncture was the predominant technique

📊 Outcome Comparison

Use of acupuncture points

ST-36
70
GB-30
18
SP-6
11
💬 What does this mean for you?

This extensive review shows that acupuncture relieves inflammatory pain through multiple simultaneous mechanisms: at the needle site, it activates cells that release calming substances; at the site of inflammation, it balances the immune system; and in the central nervous system, it reduces pain transmission. This scientifically explains why acupuncture is effective for conditions such as arthritis and chronic pain.

📝

Article summary

Plain-language narrative summary

Inflammatory pain is a complex condition that affects millions of people around the world, caused by injuries to peripheral tissues and inflammatory processes that can lead to chronic pain and progressive functional limitations. This scientific review examines how acupuncture may help in the treatment of inflammatory pain through specific mechanisms of communication between the nervous system and the immune system, offering a scientific perspective on this ancient therapy.

The study of inflammatory pain reveals that it develops through a complex process whereby tissue injuries activate immune system cells, which then release inflammatory substances. These substances not only cause local inflammation but also sensitize the nerves that detect pain, making them more sensitive to stimuli. In addition, prolonged stimulation may cause changes in the central nervous system, creating a cycle in which pain is perpetuated even after the initial injury has been repaired. The World Health Organization officially recognizes acupuncture as an effective treatment for sixteen diseases related to inflammatory pain, including rheumatoid arthritis, gastritis, and shoulder bursitis.

This research consisted of a comprehensive review of the scientific literature, analyzing studies published between 2010 and 2020. The researchers initially examined more than three thousand scientific articles, refining the selection to 97 experimental studies that investigated the mechanisms by which acupuncture relieves inflammatory pain. Most studies used well-established animal models of inflammatory pain, primarily the complete Freund's adjuvant-induced arthritis model, which simulates features of human rheumatoid arthritis. The most frequently studied acupuncture points were ST-36 (Zusanli) and other points traditionally used in the treatment of arthritic conditions.

The results revealed that acupuncture acts through three main levels of interaction between nerves and immune cells. At the site of the acupuncture points, needle insertion activates specific channels in cells, particularly TRPV1 and TRPV2 channels, promoting the release of substances such as adenosine and histamine. These substances interact with receptors on nerve terminals, initiating the therapeutic signals of acupuncture. At the sites of inflammation, acupuncture demonstrated the ability to recruit immune cells that release natural opioid peptides, providing pain relief, while also regulating the balance between pro-inflammatory and anti-inflammatory immune cells.

In the central nervous system, acupuncture inhibits communication between glial cells and neurons, reducing the release of excitatory neurotransmitters and promoting the release of pain-inhibiting substances.

For patients suffering from chronic inflammatory pain, these findings are particularly relevant because they demonstrate that acupuncture does not merely mask pain, but acts on the fundamental mechanisms that perpetuate it. The therapy has proven effective in reducing inflammatory markers such as interleukin-1β, tumor necrosis factor-α, and interleukin-6, while simultaneously increasing anti-inflammatory mediators such as interleukin-10. For health care professionals, the results provide solid scientific evidence that acupuncture can be safely integrated into conventional treatment protocols, potentially reducing dependence on anti-inflammatory medications and analgesics that may have significant side effects with prolonged use.

The research also identified several important limitations that should be considered. Most studies used animal models of acute pain rather than chronic inflammatory conditions that are more representative of human clinical conditions. Additionally, the brain mechanisms that regulate neuroimmune interactions during acupuncture treatment are not yet as well understood as the peripheral and spinal mechanisms. Another significant limitation is that many studies examined only the protective effects of acupuncture in the early phases of inflammatory pain, and more studies are needed on its efficacy in chronic inflammatory conditions.

The scientific evidence compiled in this review demonstrates that acupuncture acts through multiple integrated mechanisms that modulate both inflammation and pain transmission. By regulating communication between nerve and immune cells at different levels of the nervous system, acupuncture offers a therapeutic approach that goes beyond mere symptomatic relief, acting on the underlying causes of inflammatory pain. These findings pave the way for future research that may develop more specific and effective protocols, potentially combining acupuncture with conventional therapies for optimal pain management. For patients and professionals interested in integrative approaches to pain treatment, this research provides a robust scientific basis for considering acupuncture as a valid and evidence-based therapeutic option.

Strengths

  • 1Comprehensive analysis of 97 experimental studies
  • 2Detailed mapping of neuroimmune mechanisms
  • 3Integration of peripheral and central findings
  • 4Robust scientific basis for clinical application
⚠️

Limitations

  • 1Most studies in acute animal models
  • 2Brain mechanisms less studied than peripheral
  • 3Lack of chronic inflammatory pain models
  • 4Interaction between neurotransmitters and glia poorly explored
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Chronic inflammatory pain—rheumatoid arthritis, osteoarthritis, bursitis—represents one of the most frequent demands in pain and rheumatology services, and prolonged dependence on nonsteroidal anti-inflammatory drugs imposes cardiovascular and gastrointestinal risks that the clinician manages daily. This review, by systematically mapping the neuroimmune mechanisms of acupuncture across 97 experimental studies, provides the physician with a concrete mechanistic framework to support the therapeutic indication—not as an alternative, but as a component integrated into the conventional protocol. The documented reduction in IL-1β, TNF-α, and IL-6, accompanied by elevation of IL-10, corresponds precisely to the modulation profile sought in patients with a systemic inflammatory burden. For the rheumatologist or pain specialist, this means being able to discuss with the patient a plausible mechanism of action, as well as justifying acupuncture as an analgesic-sparing strategy in populations with polypharmacy or contraindications to first-line drugs.

Notable Findings

The fact that ST-36 was used in 70 of the 97 experimental studies is not trivial—it confirms on a bibliometric scale what classical clinical practice has consolidated over centuries, attributing to Zusanli immunomodulatory properties that now find a precise molecular substrate. The tripartite mechanism described is the structuring finding of the review: at the point of insertion, activation of TRPV1 and TRPV2 channels and the release of adenosine and histamine initiate the therapeutic signal; in inflamed tissue, recruitment of immune cells producing endogenous opioids offers local analgesia without central depression; and in the dorsal horn and supraspinal structures, inhibition of glia-neuron signaling reduces central sensitization. The predominance of electroacupuncture in more than 80% of the studies, at frequencies of 2 to 10 Hz and intensity of 1 to 2 mA, offers operational parameters directly transferable to practice—which converts a mechanistic review into an applicable protocol.

From My Experience

At the Pain Center of HC-FMUSP, inflammatory joint pain is probably the scenario where we most frequently combine acupuncture with ongoing pharmacologic treatment. I have observed that patients with controlled rheumatoid arthritis, but with residual flare-ups of pain and stiffness, respond to the first sessions between the third and fifth applications—a speed compatible with the peripheral mechanism of recruiting immune cells that produce opioids, as described in this review. The regimen we usually adopt is 8 to 12 weekly sessions in the acute phase, followed by biweekly or monthly maintenance according to clinical stability. Electroacupuncture at ST-36 with parameters close to those cited—low frequency, tolerable intensity—is our preferred choice in these cases, especially when we want to minimize the dose of corticosteroid or NSAID. The patient profile that responds best, in my experience, is the one with a predominant peripheral inflammatory component and a lesser degree of established central sensitization—exactly the population that the experimental models of this review represent with greater fidelity.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Frontiers in Neuroscience · 2021

DOI: 10.3389/fnins.2021.695670

Access original article
CITED IN · 01 PAGE

Condition pages and clinical articles that cite this evidence as the basis of their recommendations.

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.